SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001216
Filing Date
2024-08-08
Accepted
2024-08-08 16:01:28
Documents
69
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q qnrx-20240630x10q.htm   iXBRL 10-Q 1020666
2 EX-31.1 qnrx-20240630xex31d1.htm EX-31.1 13235
3 EX-31.2 qnrx-20240630xex31d2.htm EX-31.2 13217
4 EX-32.1 qnrx-20240630xex32d1.htm EX-32.1 6169
5 EX-32.2 qnrx-20240630xex32d2.htm EX-32.2 6157
  Complete submission text file 0001410578-24-001216.txt   4870115

Data Files

Seq Description Document Type Size
6 EX-101.SCH qnrx-20240630.xsd EX-101.SCH 44847
7 EX-101.CAL qnrx-20240630_cal.xml EX-101.CAL 29718
8 EX-101.DEF qnrx-20240630_def.xml EX-101.DEF 177116
9 EX-101.LAB qnrx-20240630_lab.xml EX-101.LAB 356291
10 EX-101.PRE qnrx-20240630_pre.xml EX-101.PRE 275207
72 EXTRACTED XBRL INSTANCE DOCUMENT qnrx-20240630x10q_htm.xml XML 619234
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 10-Q | Act: 34 | File No.: 001-37846 | Film No.: 241188034
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)